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Abstract: Phenylketonuria (PKU) is a genetic disorder that is characterized by an inability of the body to utilize 
the essential amino acid, phenylalanine. The disease results from a deficiency in phenylalanine hydroxylase, the 
enzyme catalyzing the conversion of phenylalanine to tyrosine. Although, this inborn error of metabolism was 
among the first in humans to be understood biochemically and genetically, little is known about the mechanisms 
involved in the pathology of PKU during neonatal brain development. Elevated concentrations of plasma 
phenylalanine were induced in pregnant rats by oral administration of 50mg/100g body weight alpha-
methylphenylalanine plus phenylalanine supplementation at a dosage of 60mg/100g body weight two times daily 
after 6th day of onset of gestation till 14 & 16 days prenatal as well as at parturition. Treatment with alpha-
methylphenylalanine resulted in significant reduction of retinal cell layers of prenatal fetuses and delivered 
newborns.   Histological abnormalities were detected manifested by either hyaline degeneration of lens structure or 
inducing lens cataract as well as comparative atrophy of retina associated with the development of malignant 
polypoid mass in the ganglionic cell layers in contact with the lens. 
 
Keywords: PKU; Eye; Perinatal; Rat. 
 
 
1. Introduction 
 
Phenylketonuria (PKU) disease was first described 
in 1934 by a Norwegian doctor named Asbjörn Fölling 
[1]. He concluded that the disorder of phenylalanine 
metabolism was the cause of the children’s mental 
retardation and gave the name Phenylketonuria to this 
condition. Subsequent examinations of PKU patients 
excreting phenylpyruvic acid proved that phenylalanine 
was accumulated in their bodies.  
In Phenylketonuria, phenylalanine accumulates in 
the blood as the result of a deficiency or malfunction of 
the liver enzyme phenylalanine hydroxylase (PAH), 
which under normal conditions converts phenylalanine 
to L-tyrosine [2]. Consequently, individuals with PKU 
are low in L-tyrosine [3] which may contribute to 
behavior problems [4].  
Phenylalanine is one of the building blocks of 
protein. It is found in protein when the phenylalanine 
hydroxylase enzyme is absent or deficient, 
phenylalanine abnormally accumulates in the blood. 
Inability to remove excess phenylalanine from the 
blood during infancy and early childhood produces a 
variety of problems including mental retardation. 
Universal newborn screening can identify genetic 
defects and these problems can be greatly reduced by 
placing the child on a special diet within the first few 
days of life [5]. 
The most common cause for a lack of this enzyme 
is a genetic defect in the gene for PAH, where most 
patients suffering from PKU have one or another of 
several possible mutations in this gene, and PAH 
activity is a defect in the generation of adequate 
amounts of the cofactor tetrahydrobiopterin (BH4). BH4 
is an essential coenzyme not only for the hydroxylation 
of phenylalanine to tyrosine but also for the 
hydroxylation of tyrosine to L-dopa required for 
dopamine biosynthesis and for the hydroxylation of 
tryptophan to 5-hydroxytryptophan, the substrate for 
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serotonin biosynthesis. This group appears to constitute 
3% of all hyperphenylalaninemia patients [6]. 
Genetic analysis, using recombinant DNA 
techniques, has established that the genetic locus for 
PKU is on chromosome 12, DNA analysis has shown 
that the classical form of the disease is due not to 
deletion of the entire gene for PAH, but is instead due 
to mutations within the gene's sequence leading to 
amino acid substitutions; results in an enzyme that does 
not work properly and therefore the body cannot 
metabolize phenylalanine (Pietz, 1998). The gene for 
PAH was cloned in [7], and by now more than 400 
different mutations in the PAH gene have been 
identified [8, 9]. Excessively, high or low levels of 
phenylalanine may occur during pregnancy, both of 
which may adversely affect the fetus [10]. Maternal 
PKU can lead to fetal malformations, mental retardation 
[11]. Adverse effects on the offspring can be reduced 
by family planning and by careful dietary control both 
prior to and during pregnancy [12]. In addition, low L-
tyrosine levels in pregnant women with PKU may 
contribute to fetal damage [13]. Untreated children with 
persistent severe hyperphenylalaninemia (Elevated 
plasma Phe concentration; HPA) show impaired brain 
development and behavior problems. The excretion of 
excessive phenylalanine and its metabolites can create a 
mousy body odor, sensitivity to sunlight and skin 
conditions such as eczema [14, 15]. The associated 
inhibition of tyrosinase is responsible for decreased 
skin and hair pigmentation, light skin. Affected 
individuals also have decreased myelin formation and 
dopamine, norepinephrine, and serotonin production. 
Further problems can emerge later in life and include 
exaggerated deep tendon reflexes and paraplegia or 
hemiplegia [14, 15]. 
The aim of the present work is to clarify the 
adverse effects of PKU on the development of optic 
region during prenatal life at 14 days of gestation and at 
parturition. 
 
2.  Materials and methods 
 
2.1.  Experimental animals 
Fifty fertile virgin females and fertile males of 
albino rats with an average body weight of 100–110 
grams (ratio of 1 male: 4 females) were obtained from 
Helwan Animal Breeding Farm and used for 
experimentation. Rats were housed in cages in the 
Animal House of Department of Zoology, Faculty of 
Science, Suez Canal University at ratio of four/cage. 
They were maintained at a temperature of 20–25°C 
with 12h light- 12h dark cycle and stayed for 
acclimatization for one week before starting the 
experiments. They were fed on standard diet composed 
of 50% grinding barley, 10% grinding Yellow Maize, 
20% milk, and 10% vegetables. Barley is an 
economical nutrient source that should be strongly 
considered in formulating ratios for dairy animals [16]. 
Water and food were available for consumption ad 
libitum throughout the experimental period. Rats were 
observed daily and only healthy animals were used in 
these experiments. 
 
2.2.  Experimental work 
Mating was carried out by housing females’ rats 
with fertile males in separate cages at a ratio of three 
females with one male for an overnight between 8 PM 
to 8 AM. The presence of vaginal blogs or the presence 
of sperms in the vaginal smear determined the zero date 
of gestation. 
The pregnant mothers were divided into two main 
groups, twenty animals per each: 
i. Control: Twenty pregnant mothers were divided 
into two subgroups ten animals in each; sacrificed at 
14th and 16th day of gestation as well as at 
parturition.  
ii. Experimental Phenylketonuria group: Each 
selected pregnant females at the 6th day of gestation 
was intragastrically administered 30mg DL–α-
methylphenylalanine/100g body weight, the applied 
dose was selected according to Rech et al., [17]. The 
twenty pregnant mothers diseased with experimental 
PKU were divided into two subgroups ten animals 
in each; sacrificed at 14th day of gestation as well as 
at parturition.  
 
2.3.  Investigated parameters 
The optic regions were separated from control and 
experimental diseased group at 14 days fetuses and 
delivered newborns to observe the manifestation of 
growth defects. 
The previously mentioned specimens were then 
washed several times in tap water, dehydrated in 
ascending grades of ethyl alcohol, cleared in terpineol 
for two days, then washed in benzene for 10 minutes 
and embedded in three changes of molten paraplast 58-
62°C. Serial 6µ thick histological sections were cut and 
stained in hematoxylin and eosin (Harris HX) [18], 
examined carefully under bright field light microscopy 
and photographed. 
 
2.4.  Statistical analysis 
Statistics were calculated with SPSS for Windows 
version 13.0. The means value obtained in the different 
groups were compared by paired student's t-test. All 
results were expressed as mean values ± SE and 
significance was defined as p<0.05 and highly 
significant when <0.01 [19]. 
 
3.  Results 
 
3.1.  Morphometric observation of the Eye 
In the observation of the morphometric 
assessments of retina thickness (µm) of fourteen-day 
fetuses and delivered newborns of experimentally 
induced PKU mothers, the results showed that both 14-
day fetuses and delivered newborns of PKU mothers 
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exhibited a marked reduction of retinal thickness 
compared with control (Table 1). 
 
Table 1. The thickness of retina (µm) of fourteen-day fetuses and 
delivered newborns of control and experimentally induced PKU 
mothers. 
 
Statistical 
parameter 
14-Days Prenatal Delivered newborn 
Control PKU Control PKU 
Mean 65.7 52.76 78.25 62 
±S.D. 3.93 2.94 9.22 2.54 
±S.E. 1.75 1.31 4.12 1.14 
T. Test - 2.36 - 2.57 
P. Value - .0006 - .0012 
Significance - s - s 
S.D. = Standard deviation; S.E. = Standard error;  
P = Probability; S = Highly significant (p<0.01). 
 
3.2.  Histological observation  
In control, eye of fourteen-day fetuses showed 
normal pattern of cornea, lens, and retina. The retina is 
formed mainly of three cell layers. The outermost layer 
in the retina is pigmented epithelium followed by the 
photoreceptor cell layers (rods and cones). Another 
layer still undifferentiated (Plate 1: A, B, C, and D). 
The optic regions of experimental diseased group 
at 14 days fetuses showed various histological 
abnormalities. Lens exhibited widespread vesicles and 
vacuoles. Much spotty degenerated area appeared. 
Massive pyknotic cell death appeared throughout 
epithelial cells lining the lens. Retina exhibited 
considerable atrophy. Ganglionic cell layers appear 
degenerated. Photoreceptor cells possessed either 
pyknotic or karyolytic nuclei. The photoreceptor cell 
layers exhibited massive vacuolar degeneration and 
pyknosis in most nuclei (Plate 2: A, B, C, and D). 
In control delivered newborns, the lens attained a 
considerable growth and differentiation. The retina is 
composed of many layers from the outside inwards; the 
pigmented epithelium, the photoreceptor, outer nuclear, 
outer plexiform, inner plexiform, inner nuclear and the 
innermost layer of the retina, the ganglionic cell layer 
appears degenerated (Plate 3: A, B, C, and D). In 
newborns of experimentally induced PKU mother, there 
was a considerable swelling and degeneration of lens 
fibers enclosed almost. The retinal cell layers attained a 
considerable atrophy. The ganglionic cell layers 
appeared sloughing and degenerated. Different zones of 
degenerated photoreceptor cell layers were detected. In 
some specimens, the retinal cell layer detached and 
formed polyploid tumor masses projected toward the 
lens (Plate 4: A, B, C, and D). 
 
 
Plate 1(A – D). Photomicrographs of histological sections of eye region of control 14th days fetuses showing, normal pattern of cornea, lens, 
and retina. The retina formed of pigmented epithelium (pe), photoreceptor cell layer (ph) and ganglionic cell layer (g) and other layers were 
still undifferentiated (A: X 40-B: X 100-C: X 400). 
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Plate 2(A - C). Photomicrographs of histological sections of eye region of 14-days fetuses of experimentally induced PKU mother showing, 
widespread of vesicles, vacuoles and degeneration appeared throughout epithelial cells lining the lens. Retina exhibited considerable 
atrophy with degenerated ganglionic cell layer (g). Photoreceptor cells (ph) possessed either pyknotic (py) or karyolytic (kl) nuclei (A: X 40 – 
B: X 100 – C: X 400). 
 
 
Plate 3(A - D). Photomicrographs of histological sections of eye region of control offsprings showing, normal characteristic pattern of both 
lens and retina. The retina showed differentiated cell layers; the photoreceptor (ph) outer plexiform (opl), outer nuclear (onl), inner 
plexiform (ipl), inner nuclear (inl) and ganglionic cell layer (A:X 40 – B:X 100- C: X 200 – D:X 400). 
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Plate 4(A - D). Photomicrographs of histological sections of eye region of offsprings of experimentally induced PKU mother showing, massive 
degeneration of the lens with peculiar spongy fibrotic characteristic appearance manifesting cataract formation. The lens fibers appeared 
sloughing and degenerated. The retina attains a considerable atrophy with massive degeneration of their cell layer content. A striking 
formation of polyp projected toward the lens (A: X 40 – B: X 40 – C: X 100- D: X 400). 
 
4.  Discussion 
 
Phenylketonuria (PKU) is an inherited metabolic 
disease, carried through a "recessive" gene. 
Phenylalanine hydroxylase deficiency is caused by 
mutations in the PAH gene, resulting in a primary 
deficiency of the liver enzyme phenylalanine 
hydroxylase (PAH) [20-22], and consequently interrupt 
the conversion of amino acid phenylalanine to another 
amino acid tyrosine, that results in excessive 
accumulation of the amino acid phenylalanine and 
reduced levels of the amino acid L-tyrosine in the blood 
[23]. Thus, phenylalanine accumulates in the blood to a 
concentration sufficiently high to activate an alternative 
pathway of degeneration [24, 25]. Attempts to reveal 
the adverse effects of PKU on the growth of optic 
region during prenatal life at 14 days of gestation and at 
parturition understand the underlying cause for the 
abnormalities associated with maternal PKU have led to 
the use of animal model in which the histopathological 
investigations were encountered in optic region to 
clarify the disease pattern [25]. 
Exposure to the mother’s metabolic abnormalities 
affects the fetus during the entire pregnancy. The 
abnormalities produced by the PKU mothers are not 
genetic, but "Intrauterine Environmental." Our results 
and those of others confirm this hypothesis. Jervis [26] 
stated that the damage to the children of PKU mothers 
is not a genetic consequence (although the children will 
be at least heterozygous, as PKU is an autosomal 
recessive disorder). This can be proven by the fact that 
PKU fathers produce normal offsprings [27] and also 
that well-controlled pregnant PKU mothers can produce 
children without obvious handicap. 
Above symptoms result from high Phe 
concentrations in the blood of the fetus. It is a 
consequence of intrauterine Phe excess resulting from 
the positive transplacental Phe gradient. To keep fetal 
blood Phe below 500µmol/l, maternal concentration 
should be below 300µmol/l [28, 29]. 
Austic and Grau [30] used the yolk sac perfusion 
technique whereby the yolk of embryos is replaced by 
defined media to study the effect of Phe and Tyr 
deficiency on 4-7 day old chick embryos. Both 
deficiencies resulted in severe degeneration of the 
neural retina and brain, scattered pyknosis in the spinal 
cord and cranial and spinal ganglia, and vacuolization 
of the lens in the region of lens fiber development. With 
the exception of the lens, the effects of Phe and Tyr 
deficiency appeared to be restricted to tissues of neural 
origin. In an experiment conducted to determine the 
ability of Phe to substitute for Tyr, the addition of Phe 
to the perfusion medium not only failed to relieve the 
symptoms of Tyr deficiency, but it caused a reduction 
of eye pigmentation, which caused by the inability of 
chick embryos to convert Phe to Tyr. 
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Andersen et al., [31] reproduced the biochemical 
features of PKU in developing rat pups by 
administering to them a combination of p-chloro-DL-
phenylalanine plus L-phenylalanine for the first 21 days 
after birth. During the treatment period, the 
experimental animals show delayed eye opening and 
significantly decreased brain and body weight 
compared with controls given saline. Neuropathological 
examination of developing animals reveals deficient 
myelination and some inhibition of cerebellar 
maturation. Rats treated with p-chloro-DL-
phenylalanine plus L-phenylalanine during the 
vulnerable period of rapid brain development, thus have 
enduring behavioral changes that persist throughout 
life. 
Wen et al., [32] indicated that the suckling rat 
treated with phenylacetate should be a useful new 
model for studying the pathogenesis of PKU and 
neuronal development. Both cerebellar and retinal 
neurons of postnatally treated rats are vulnerable to the 
adverse effects of phenylacetate. Morphological 
changes observed in the cerebellum, retina, and optic 
nerve of treated animals during the fourth to twenty-
first days of life consist of regional reductions in the 
size of cerebellar vermis lobules IV, V, VI, and IX, 35 
to 40% reduction in thickness of the molecular layer, 
accumulation of cerebellar external granular cells and 
retinal neuroballistic cells, fewer parallel fibers in the 
cerebellar cortex, and few myelinated axons in the optic 
nerve. 
Diamond and Herzberg [33] recorded impaired 
sensitivity to visual contrast in 12 children with 
Phenylketonuria aged 5.4-9.8 years, despite early and 
continued treatment and despite phenylalanine levels 
within acceptable limits. They interpreted these 
findings as support for Diamond's hypothesis that 
moderately elevated plasma Phe levels (3-5x normal), 
combined with reduced plasma tyrosine, moderately 
reduce the levels of Tyr reaching the eye and brain, 
which adversely affects those dopamine neurons that 
fire and turn over dopamine most rapidly (the dopamine 
neurons in the retina and those projecting to prefrontal 
cortex). This would lead to the deficit in contrast 
sensitivity found here and to the selective deficit in 
prefrontal cortex cognitive functions previously 
reported in PKU children under moderately good 
dietary control. 
Recognizing that a phenylalanine diet, low in the 
LC-PUFA’s is necessary for cell membrane formation 
and normal brain and visual development, Agostoni et 
al., [34] examined the effects of a 12-month 
supplementation of LC-PUFA’s on fatty acid 
composition of erythrocyte lipids and visual evoked 
potentials in children with well-controlled PKU. The 
children who received supplementation showed a 
significant increase in docosahexaenoic acid levels of 
erythrocyte lipids and improved visual function. 
Disturbance of phenylalanine metabolism 
interferes with the formation of unusual metabolites 
causing adverse effects of the development of eye 
regions either directly or via its effects on dopamine’s, 
which reproduce the cytotoxicity manifested in both 
retina and lens [22]. 
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